Related Experiment Video
Updated: May 21, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Management of DYT1 dystonia throughout pregnancy
Sathiji Nageshwaran1, Saiji Nageshwaran, Mark J Edwards
1University College London, London, UK. zchabq4@ucl.ac.uk
Abstract:
A 30-year-old woman with generalised DYT1 dystonia, controlled with medication, presented at 9 weeks gestation with an unplanned pregnancy. A number of learning points were highlighted in management of the patient's dystonia alongside pregnancy including avoidance of excessive medication exposure to the fetus, while maintaining symptom control to a level acceptable and safe for the patient and prenatal diagnostic testing. In our case there was no overt ill effect to the newborn. This is a common worry among pregnant women with dystonia and as such the authors felt it important to report.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Alterations in Muscle Tone ll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Skeletal Muscle Relaxants: Therapeutic Uses
Alterations in Muscle Tone lll
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

